OVERVIEW
Muscle glycogenosis (GSDs) is an important group of potentially treatable inherited muscle disorders affecting childrenand adults.
Major advances have been achieved in the diagnosisof these disorders over the past years thanks to improvements in biochemical and molecular techniques.
Better understanding of the phenotypes and clinical course of the various glycogenosis has led to improved multidisciplinary approach to care, follow-up and improved outcomes.
Depending on the aetiologies, various therapeutic approaches are available such as specific diets, enzyme replacement therapy, exercise, and novel drugs or gene therapy are in the pipeline.

TARGETAUDIENCE
This course is aimed at paediatricians, neurologists, neuromuscularspecialists, internists, cardiologists, geneticists, biochemists, and othercliniciansand scientistswilling to improve their knowledge in the diagnosis and treatment of muscle glycogenosis + differential diagnosis with other metabolic myopathies.

SCIENTIFICORGANISINGCOMMITTEE
•Prof. Pascal Laforêt, Paris
•Prof. Nadine van der Beek, Rotterdam
•Prof. Ans van der Ploeg, Rotterdam
•Prof. John Vissing, Copenhagen

| Website
| Scientific Programme